BioFilm Control has already established and is still actively seeking strategic and commercial partnerships in the following areas:
Business Development Partnerships:
Develop predictive and diagnostic tests in the area of infective diseases
- Predicting risks of severe urinary infections with a simple, reproducible, automatable and information rich test: An up to 5 billion USD opportunity in the pregnancy follow-up market.
Create new value to existing banks of molecules:
- High throughput screening campaigns towards banks of molecules to discover new molecules active against biofilms: Fee For Service or co-develop.
- Screen molecules already passed phase IIa, but not efficient on initial indication: Fee For Service or co-develop.
Discover and develop new anti-biofilm molecules:
- License molecules discovered in BioFilm Control internal research
- Co-discover molecules in internal research: BioFilm Control identifies molecules from smart sources, up-front fee to pay for R&D costs, milestone payments, royalties : exclusive or non exclusive.
Commercial Partnerships:
Cleaning of pharmaceutical and industrial production plants:
We are keen to consider distributor partnerships for subsets of our activities in defined fields or geographical areas
Technological Partnerships:
We are developping new applications for our technology: polysaccharide enzymology, Polytech' Clermont, Prof. Michaud
We are devolpping our core technology: CNRS Rouen, Dr Jouenne.